This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Eli Lilly & Company
Drug Names(s): pemetrexed, LY231514
Description: Alimta (Pemetrexed for injection) is an antifolate antineoplastic agent that exerts its action by disrupting folate-dependent metabolic processes essential for cell replication. It main mechanism of action is the inhibition of the folate-dependent enzyme thymidylate synthase (TS) resulting in inhibition of de novo thymidylate and DNA synthesis.
Pink Sheet Alimta Clinical Development
Additional information available to subscribers only: